Living Donor Liver Transplantation for Alcohol-related Liver Disease: An Intention-to-treat Analysis DOI
Christian Tibor Josef Magyar, Owen Jones, Luckshi Rajendran

et al.

Transplantation, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Background. Alcohol-associated liver disease (ALD) is the leading indication for transplantation (LT) in Western world. Although 6 mo of abstinence no longer a criterion patients with ALD, outcomes living donor LT (LDLT) versus deceased (DDLT) are not well established. Methodss. We performed an intention-to-treat analysis to evaluate impact listing and pursuing primary LDLT (pLDLT) compared DDLT (pDDLT). The endpoint was overall survival from date listing, evaluated using Cox regression (hazard ratios). Results. Two hundred thirty-three ALD were listed LT, which 27 (12%) pLDLT. median model end-stage (MELD) score at 20 Na-MELD 24, 4.5 mo, 128 (55%) underwent transplantation. There statistically significant adjusted difference 3-y between pLDLT pDDLT (adjusted hazard ratio [HR] 0.72; P = 0.550) as-treated (HR 1.22; 0.741). No delisted group, whereas 86 (42%) group; primarily because death (46 [50%]) medical improvement (24 [28%]). Alcohol use since time documented 29 (13%) patients; immortal bias found HR 1.07; 0.900) 2.95; 0.130). Conclusions. Patients benefit intention lower rates waitlist dropout delisting, attributable mortality or deterioration, should be encouraged pursue this option.

Language: Английский

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies DOI
Parag Jain,

Akanksha Jain,

Rohitas Deshmukh

et al.

Clinics and Research in Hepatology and Gastroenterology, Journal Year: 2025, Volume and Issue: unknown, P. 102584 - 102584

Published: March 1, 2025

Language: Английский

Citations

0

EORTC consensus recommendations on the optimal management of colorectal Cancer liver metastases DOI
Giacomo Bregni, Richard Adams, Reto Bale

et al.

Cancer Treatment Reviews, Journal Year: 2025, Volume and Issue: unknown, P. 102926 - 102926

Published: March 1, 2025

Language: Английский

Citations

0

Ginseng and its functional components in non-alcoholic fatty liver disease: therapeutic effects and multi-target pharmacological mechanisms DOI Creative Commons
Ping Xiao,

Ziru Ye,

Xiuyan Li

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: April 9, 2025

Non-alcoholic fatty liver disease (NAFLD) is a common type of chronic and its incidence increasing. Its progression closely related to non-alcoholic steatohepatitis fibrosis. Effective treatment currently lacking. The traditional Chinese medicine ginseng (Panax ginseng) shows unique advantages in NAFLD intervention, but complex compositional system molecular mechanism network still need be systematically analyzed. This paper integrates evidence from nearly 20 years research elucidate the multi-target pharmacological for NAFLD. Relevant information was sourced Pubmed, Web science, Embase CNKI databases. Using BioRender visio draw biomedical illustrations. active ingredients contain 2 classes saponins (tetracyclic triterpene saponins, pentacyclic other modified types) non-saponins. Different cultivation methods, processing techniques extraction sites have expanded variety constituents demonstrated different activities. Studies shown that functional components ability regulate lipid metabolism disorders, inflammation, oxidative stress, endoplasmic reticulum insulin resistance, disruption intestinal flora structure, cell death senescence. Demonstrates potential study reveals first time integrative through tertiary mode action "multi-component multi-pathway". multilevel modulatory provides new direction development comprehensive therapeutic strategies

Language: Английский

Citations

0

Regional Variations and Trends in Liver Transplantation Practices Across Europe DOI Creative Commons
Tommaso Di Maira,

Valérie Cailliez,

Beatriz Domínguez‐Gil

et al.

JHEP Reports, Journal Year: 2025, Volume and Issue: unknown, P. 101424 - 101424

Published: April 1, 2025

Language: Английский

Citations

0

Living Donor Liver Transplantation for Alcohol-related Liver Disease: An Intention-to-treat Analysis DOI
Christian Tibor Josef Magyar, Owen Jones, Luckshi Rajendran

et al.

Transplantation, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Background. Alcohol-associated liver disease (ALD) is the leading indication for transplantation (LT) in Western world. Although 6 mo of abstinence no longer a criterion patients with ALD, outcomes living donor LT (LDLT) versus deceased (DDLT) are not well established. Methodss. We performed an intention-to-treat analysis to evaluate impact listing and pursuing primary LDLT (pLDLT) compared DDLT (pDDLT). The endpoint was overall survival from date listing, evaluated using Cox regression (hazard ratios). Results. Two hundred thirty-three ALD were listed LT, which 27 (12%) pLDLT. median model end-stage (MELD) score at 20 Na-MELD 24, 4.5 mo, 128 (55%) underwent transplantation. There statistically significant adjusted difference 3-y between pLDLT pDDLT (adjusted hazard ratio [HR] 0.72; P = 0.550) as-treated (HR 1.22; 0.741). No delisted group, whereas 86 (42%) group; primarily because death (46 [50%]) medical improvement (24 [28%]). Alcohol use since time documented 29 (13%) patients; immortal bias found HR 1.07; 0.900) 2.95; 0.130). Conclusions. Patients benefit intention lower rates waitlist dropout delisting, attributable mortality or deterioration, should be encouraged pursue this option.

Language: Английский

Citations

0